SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Painkiller heart risk revealed

Thursday May 30th, 2013

Most common pain-killers pose a small risk to the heart - but doctors should be able to calculate which drugs pose the greatest risk to individual patients, experts reveal today.

A major analysis, published in The Lancet, says that new drugs, known as coxibs, as well as high doses of older drugs, such as ibuprofen and diclofenac, all pose similar risks.

The drugs, known as non-steroidal anti-inflammatory drugs, are used widely to treat conditions such as rheumatoid arthritis.

The study suggests that for every 1,000 people with a moderate risk of heart disease who take the drugs, three extra will suffer a heart attack and one extra will die because of the treatment.

The researchers looked at 639 trials involving more than 353,000 patients.

Researcher Professor Colin Baigent, from Oxford University, UK, said: "We would emphasise that the risks are mainly relevant to people with arthritis who need to take high doses over a long period. A short course of lower dose tablets purchased without a prescription, for example, for a muscle sprain, is not likely to be hazardous."

He added: "This new research shows how to calculate the likely size of any risks of NSAIDs for an individual patient, which should help doctors and their patients when they consider the treatment options."

The medical director of Arthritis Research UK, Professor Alan Silman, said the findings highlighted an "urgent" need to find alternative treatments.

He said: "GPs are aware of the risks of NSAIDs, and there has been a marked reduction in the use of diclofenac and a switch to naproxen in recent years. For patients with arthritis, not smoking, a healthy diet and having their blood pressure checked regularly are more important factors in reducing the risk of a heart attack.

"We would advise people with arthritis who are taking NSAIDs not to be unduly concerned by these latest findings and to seek the advice of their GP."

Lancet 30 May 2013 [abstract]

Tags: Heart Health | Pain Relief | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

CATEGORIES